ClinicalCalc Pro - Free Medical Calculators for Doctors & Physicians

MELD and MELD-Na: The Complete Guide to Liver Transplant Prioritisation
Clinical GuidesMELD ScoreMELD-NaLiver TransplantCirrhosis

MELD and MELD-Na: The Complete Guide to Liver Transplant Prioritisation

Dr. Sarah Mitchell

Dr. Sarah Mitchell

Interventional Cardiologist

December 22, 20247 min read

MELD-Na replaced standard MELD for organ allocation in 2016. Understand the formula, the sodium correction, and how to use these scores to guide transplant listing decisions and predict 90-day waitlist mortality.

From TIPS to Transplant Allocation

The MELD score was originally developed to predict 3-month mortality after TIPS procedures. Its objectivity — using only laboratory values — made it far superior to the subjective Child-Pugh score for organ allocation. UNOS adopted MELD in 2002, and MELD-Na in 2016.

The MELD Formula

MELD = 9.57 × ln(Creatinine) + 3.78 × ln(Bilirubin) + 11.20 × ln(INR) + 6.43

Creatinine is capped at 4.0 mg/dL. Patients on dialysis twice in the preceding week are automatically assigned creatinine = 4.0.

Why MELD-Na?

Hyponatraemia (serum sodium < 135 mEq/L) is independently associated with 2–3× increased 90-day waitlist mortality in cirrhosis. The MELD-Na formula:

MELD-Na = MELD + 1.32 × (137 − Na) − [0.033 × MELD × (137 − Na)]

Sodium is capped at 125–137 mEq/L to prevent gaming by aggressive sodium correction.

Score Interpretation

MELD-Na3-Month MortalityClinical Action
< 10~2%Outpatient monitoring
10–14~6%Regular hepatology follow-up
15–19~20%Transplant listing consideration
20–29~20–25%Active transplant listing
30–39~50%Priority listing
≥ 40~70%Urgent allocation

Practical Pearls

Do not aggressively correct hyponatraemia before listing — rapid sodium correction risks osmotic demyelination syndrome. Maximum correction: 8–10 mEq/L per 24 hours. MELD ≥ 15: Transplant listing benefits outweigh operative risk — this is the UNOS threshold for listing consideration. MELD does not capture portal hypertension complications (ascites, encephalopathy, variceal haemorrhage). Always use alongside clinical assessment. Hepatocellular carcinoma exception points: Patients with HCC within Milan criteria receive MELD exception points to account for tumour progression risk not captured by MELD.

Child-Pugh vs. MELD

Child-Pugh remains useful for:

  • Surgical risk assessment
  • Drug dosing in liver disease
  • BCLC staging for HCC
  • Communication with patients (Class A/B/C is intuitive)

MELD-Na is preferred for:

  • Transplant waitlist prioritisation
  • Predicting 90-day mortality
  • Objective serial monitoring

Clinical Disclaimer

This article is intended for educational purposes and clinical decision support only. Always correlate with the individual patient's clinical context, institutional guidelines, and current evidence. ClinicalCalc Pro does not replace clinical judgment.

Tags

MELD ScoreMELD-NaLiver TransplantCirrhosisChild-Pugh
Open Calculators